openPR Logo
Press release

What's driving the Gout Therapeutics Market Size? AstraZeneca, Horizon Pharma plc, Takeda Pharmaceutical Company Limited, GlaxoSmithKline plc, Novartis AG, Merck & Co. Inc

03-16-2020 05:42 AM CET | Health & Medicine

Press release from: marketstudyreport.com

/ PR Agency: marketstudyreport
What's driving the Gout Therapeutics Market Size? AstraZeneca,

MarketStudyReport.com Adds New Report Gout Therapeutics Market 2019 - 2026 research report providing information and data By Drug Class, By Disease Condition, By Region, Industry Analysis, Regional Outlook, Growth Potential, Competitive Market Share & Forecast spreading across 112 Pages with table and figures in it.

NSAIDs, corticosteroids are among the approved drugs for treating gout condition and are available for purchase over the counter. These drugs are observed to be greatly effective in treating mild gout conditions and are expected to have significant impact on driving the growth in global gout therapeutics market. Moreover, rising preference for combination therapies due to benefits such as speeding up the treatment process, reduction in side effects is also another factor enhancing the market growth.

Request a sample of this premium report at: https://www.marketstudyreport.com/request-a-sample/1868592/?utm_source=Openpr.com-AN

The incidence of gout has witnessed continual growth over the past years. It is majorly caused by uncontrolled metabolic disorder and high level of uric acid in the body. U.S. region is observed to have a high prevalence of gout owing to lifestyle issues such as high alcohol intake, obesity, and smoking resulting in the inflammatory disorder. Attributed to these factors along with the adoption of innovative treatments and increased understanding about arthritic conditions, the market in North America region is observed to be the dominant market across all regions during 2018. While, the Asia Pacific regional market is expected to witness highest growth rate owing to rising healthcare expenditure among the developing economies and significant investments by key players in this region.

The global gout therapeutics market is predicted to grow at a CAGR of 15.2% from 2019 to 2026 to reach USD 9,815.6 million by 2026, according to a new market report. The report Gout Therapeutics Market Size, Share, Trends & Analysis Report, By Drug Class (Urate-Lowering Agents, Corticosteroids, Nonsteroidal Anti-inflammatory Drugs [NSAIDs], Colchicine); By Disease Condition (Chronic Gout, Acute Gout); By Region, Segment Forecast, 2019 - 2026 provides in depth analysis of the current and future market trends.

As per the severity of gout condition recommendations of medications and therapies are made to the respective patients. Multiple pharmaceutical companies have consistently increased the R&D investments to come up with further effective medications. The market for therapeutics of acute and chronic gout has witnessed significant growth over the past years and is expected to continue its growth trend. Although both segments are anticipated to grow, chronic gout segment presently holds major market share.

Request a discount on standard prices of this premium report at: https://www.marketstudyreport.com/check-for-discount/1868592/?utm_source=Openpr.com-AN

Some of the key players in this market are AstraZeneca, Horizon Pharma plc, Takeda Pharmaceutical Company Limited, GlaxoSmithKline plc, Novartis AG, Merck & Co. Inc., Teijin Pharma Limited, Regeneron Pharmaceuticals, Inc., Ironwood Pharmaceuticals, Inc., JW Pharmaceutical, Selecta Biosciences, Inc., and Grunenthal Group. Companies are also increasingly having their focus on regenerative medicines which is further expected to contribute in the growth of gout therapeutics market.

Table of content:

1. Overview and Scope
1.1. Research goal & scope
1.2. Research assumptions
1.3. Research Methodology
1.3.1. Primary data sources
1.3.2. Secondary data sources
1.4. Key take-aways
1.5. Stakeholders
2. Executive Summary
2.1. Market Definition
2.2. Market Segmentation
3. Global Gout Therapeutics Testing Market Insights
3.1. Gout Therapeutics Market ? Industry snapshot
3.2. Gout Therapeutics Market ? Ecosystem analysis
3.3. Gout Therapeutics Market ? Market dynamics
3.3.1. Gout Therapeutics Market ? Market Forces
3.3.1.1. Gout Therapeutics Market - Market driver analysis
3.3.1.2. Gout Therapeutics Market - Market restraint/challenges analysis
3.3.1.3. Gout Therapeutics Market - Market opportunity analysis
3.4. Industry analysis - Porter's five force
3.4.1. Bargaining power of supplier
3.4.2. Bargaining power of buyer
3.4.3. Threat of substitute
3.4.4. Threat of new entrant
3.4.5. Degree of competition
3.5. Gout Therapeutics Market PEST analysis, 2017
3.6. Value Chain Analysis
3.7. Gout Therapeutics Market Industry trends
4. Gout Therapeutics Market Size and Forecast by Drug Class
4.1. Key findings
4.2. Urate-Lowering Agents
4.3. Corticosteroids
4.4. Non-steroidal Anti-Inflammatory Drugs [NSAIDs]
4.5. Colchicine
5. Gout Therapeutics Market Size and Forecast by Disease Condition
5.1. Key findings
5.2. Chronic Gout
5.3. Acute Gout
6. Gout Therapeutics Market Size and Forecast by Regions
6.1. Key findings
6.2. North America
6.2.1. U.S.
6.2.2. Canada
6.3. Europe
6.3.1. Germany
6.3.2. UK
6.3.3. France
6.3.4. Italy
6.3.5. Spain
6.3.6. Belgium

Related Report:

Global Gout Therapeutics Market Size, Status and Forecast 2019-2025

Increased research and development in the field has yielded significantly more effective medications in the recent times, which are recommended to patients on the basis of severity of the condition. Introduction of urate-lowering agents is one of the primary driver of the gout therapeutics market. First line therapies such as Febuxostat and Allopurinol are now replaced urate-lowering agents such as Lesinurad, which help in reducing pain as well as negotiate the risk of joint destruction. The growing popularity of OTC drugs such as Oral colchicine, corticosteroids, and NASAIDs, which are quite effective in moderate gout indications, are also favoring the global gout therapeutics market in the positive direction. Technological advancements in medical imaging is another factor augmenting the demand in the gout therapeutics market. On the other hand, low levels of physician and patient awareness, heavy dependency on generic drugs, and use of CAM for the treatment of gout are restraining factors over the global gout therapeutics market.

https://www.marketstudyreport.com/reports/global-gout-therapeutics-market-size-status-and-forecast-2019-2025/?utm_source=Open.com-AN

Contact Us:
Market Study Report LLC
4 North Main Street,
Selbyville, Delaware 19975
USA
Phone: 1-302-273-0910
US Toll Free: 1-866-764-2150
Email: sales@marketstudyreport.com
Website: https://www.marketstudyreport.com
Blog: https://www.marketstudyreport.com/blog

About Us:
Marketstudyreport.com allows you to manage and control all corporate research purchases to consolidate billing and vendor management. You can eliminate duplicate purchases and customize your content and license management.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release What's driving the Gout Therapeutics Market Size? AstraZeneca, Horizon Pharma plc, Takeda Pharmaceutical Company Limited, GlaxoSmithKline plc, Novartis AG, Merck & Co. Inc here

News-ID: 1967621 • Views: 489

More Releases from marketstudyreport.com

Covid -19 Impact on Video Conferencing Market Size 2026: Top Companies, Trends a …
Market Study Report recently introduced new title on “2020-2026 Global Video Conferencing Market Report” from its database. The report provides study with in-depth overview, describing about the Product, Industry Scope and elaborates Market size outlook and status to 2026. Video Conferencing Market size is anticipated to grow at over 19% CAGR between 2020 and 2026. The global video conferencing market is set to register a tremendous rise in its growth
What's driving the Patient Monitoring Devices Market Size? Fukuda, Philips, Skan …
Selbyville, Delaware the prime objective of Patient Monitoring Devices report is to help the user understand the market in terms of its definition, segmentation, market potential, influential trends, and the challenges that the market is facing. Deep researches and analysis were done during the preparation of the report. Wireless segment is anticipated to witness more than 5% growth over the forecast period. Substantial growth can be attributed to rising preference for
What's driving the 3D Implants Market trends? Stryker, Smith and Nephew, DJO Glo …
The 3D Implants market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations. Request a sample Report of 3D Implants Market at: https://www.marketstudyreport.com/request-a-sample/2679238/?utm_source=OPR.com/&utm_medium=SP The most likely (base case) scenario
Artificial Vascular Implants Market is thriving worldwide by 2025 | Top Key Play …
Global Artificial Vascular Implants Market Report added at Market Study Report LLC offers industry size, share, growth, trends and forecast analysis up to 2025. Artificial Vascular Implants Market Report also covers top key players, porters five forces analysis and market segmentation in detail. This report examines the global Artificial Vascular Implants market and provides information regarding the revenue for the period 2020 to 2025. The Artificial Vascular Implants market report provides

All 5 Releases


More Releases for Gout

Gout Therapeutics Market - Notable Growth Highlights 2025 | GlaxoSmithKline, Che …
Global Gout Therapeutics Market: Snapshot The objective of treatment during a severe gout attack involves suppressing inflammation and controlling pain. The treatment of inflammation and pain can be attained with non-steroidal anti-inflammatory drugs, colchicine, or corticosteroids. The line of treatment chosen that would be suitable depends on the co-morbid medical conditions of the patient, side effect profile, and other medications. Patients with multiple episodes of severe gout attacks every year or with
Gout Therapeutics Market Is Booming Worldwide | Takeda Pharmaceutical Company, N …
HTF MI recently introduced Global Gout Therapeutics Market study with in-depth overview, describing about the Product / Industry Scope and elaborates market outlook and status to 2023. The market Study is segmented by key regions which is accelerating the marketization. At present, the market is developing its presence and some of the key players from the complete study are Takeda Pharmaceutical Company, Novartis, AstraZeneca, GlaxoSmithKline, Merck & Regeneron Pharmaceuticals etc.
Gout Therapeutics Market - Growth Management 2017-2025
Global Gout Therapeutics Market: Snapshot The objective of treatment during a severe gout attack involves suppressing inflammation and controlling pain. The treatment of inflammation and pain can be attained with non-steroidal anti-inflammatory drugs, colchicine, or corticosteroids. The line of treatment chosen that would be suitable depends on the co-morbid medical conditions of the patient, side effect profile, and other medications. Request Sample Copy of the Report @ https://www.tmrresearch.com/sample/sample?flag=B&rep_id=2549 Patients with multiple episodes of
Gout Therapeutics Market Moderately consolidated by 2025
Global Gout Therapeutics Market: Snapshot The objective of treatment during a severe gout attack involves suppressing inflammation and controlling pain. The treatment of inflammation and pain can be attained with non-steroidal anti-inflammatory drugs, colchicine, or corticosteroids. The line of treatment chosen that would be suitable depends on the co-morbid medical conditions of the patient, side effect profile, and other medications. Patients with multiple episodes of severe gout attacks every year or with
Gout Disease Treatment Market: Report Scope and Market Segmentation 2020
Gout is a disease characterized by recurrent attacks of acute inflammatory arthritis. It occurs when urate crystals accumulate in joint and causes inflammation and intense pain. Urate crystals are formed when high levels of uric acid are present in blood. Human body produces uric acid when it breaks down into purines. Purines are those substances which are present naturally in the body in the form of foods. The global Gout disease
Gout Therapeutics - Emerging Markets in Developing Countries
Qyresearchreports include new market research report Gout Therapeutics to its huge collection of research reports. The global market for Gout Therapeutics is discussed in detail within a new research study added recently to QYResearchReports.com. The report has been carefully examined both qualitatively and quantitatively and the results are revealed in the research report for the forecast period of 2017 to 2022. In addition to this, the various drivers and restraints, regulatory